COLBENEMID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Colbenemid, and what generic alternatives are available?
Colbenemid is a drug marketed by Merck and is included in one NDA.
The generic ingredient in COLBENEMID is colchicine; probenecid. There are sixteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the colchicine; probenecid profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for COLBENEMID?
- What are the global sales for COLBENEMID?
- What is Average Wholesale Price for COLBENEMID?
Summary for COLBENEMID
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
DailyMed Link: | COLBENEMID at DailyMed |
US Patents and Regulatory Information for COLBENEMID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Merck | COLBENEMID | colchicine; probenecid | TABLET;ORAL | 012383-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |